Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01498783 · ClinicalTrials.gov registry record · Phase 1
Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma
A Phase 1 study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT01498783 is a Phase 1 study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 26 participants.
The verdict
NCT01498783, a Phase 1 study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
This is a phase I study to investigate the safety and pharmacokinetics of weekly 5-fluorouracil (5-FU) administered as a bolus dose in children and young adults with recurrent or refractory ependymoma. The results from this study will inform a subsequent phase II St. Jude investigator-initiated trial.
Interventions
- DRUG 5-fluorouracil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01498783
The ClinicalTrials.gov registry entry for NCT01498783 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 5-fluorouracil is the first listed.
NCT01498783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01498783 about?
NCT01498783 is a clinical study titled "Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma". This is a phase I study to investigate the safety and pharmacokinetics of weekly 5-fluorouracil (5-FU) administered as a bolus dose in children and young adults with recurrent or refractory ependymoma. The results from this study will inform a subsequent phase II St. Jude investigator-initiated tria...
What is the current status of trial NCT01498783?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2011-12. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01498783?
The interventions under investigation include: 5-fluorouracil (DRUG).
Who is sponsoring clinical trial NCT01498783?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.